Impact of Moderate Intensity Physical Activities on PK-guided EHL FVIII Concentrates Prophylaxis Severe HA Patients
Status:
Completed
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
To compare clinical outcomes before and after using combination between moderate to
vigorous-intensity physical activities and pharmacokinetic-guided extended half-life FVIII
concentrates prophylaxis in moderate to severe hemophilia A patients